PRESENTATIONS: PART 2

A brief overview of what you can expect from part 2 of the 2022 Global Colorectal Cancer Congress from GCCA President, Nicole Sheahan.

Global CRC patient-centered policy roundtable discussion on establishing an advocacy roadmap for organizations and patient advocates to effect change.  

President and Managing Director of Stop Darmkanker discusses developing eye-catching campaigns and provides valuable social media tips to engage your audience.

This session discusses the importance of genetic testing for DPD deficiency prior to chemotherapy with Fluorouracil (5-FU) or Capecitabine (Xeloda). 

An overview of biologics and biosimilar medicines.  Our expert speakers share how advocates can bring the patient voice to biosimilar policies around the world. For more information on biosimilars, check out GCCA's Biosimilars Training Program.

Best practices and communication strategies for patient advocacy organizations to help build relationships, navigate sponsorships, and programming support from the biopharmaceutical industry.

A brief wrap-up of the 2 part event.